225 related articles for article (PubMed ID: 37781966)
1. Lidocaine as an anti-arrhythmic drug: Are there any indications left?
Güler S; Könemann H; Wolfes J; Güner F; Ellermann C; Rath B; Frommeyer G; Lange PS; Köbe J; Reinke F; Eckardt L
Clin Transl Sci; 2023 Dec; 16(12):2429-2437. PubMed ID: 37781966
[TBL] [Abstract][Full Text] [Related]
2. Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers.
Lu HR; Rohrbacher J; Vlaminckx E; Van Ammel K; Yan GX; Gallacher DJ
Br J Pharmacol; 2010 May; 160(1):60-76. PubMed ID: 20331615
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone in ventricular arrhythmias: still a valuable resource?
Pannone L; D'Angelo G; Gulletta S; Falasconi G; Brugliera L; Frontera A; Cianfanelli L; Baldetti L; Ossola P; Melillo F; De Blasi G; Malatino L; Landoni G; Margonato A; Della Bella P; Zacchetti D; Vergara P
Rev Cardiovasc Med; 2021 Dec; 22(4):1383-1392. PubMed ID: 34957778
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic drugs in cardiac arrest resuscitation: intravenous amiodarone or intravenous lidocaine?
Singh BN
J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):61-4. PubMed ID: 12075393
[No Abstract] [Full Text] [Related]
5. Acute cardiodepressant effects induced by bolus intravenous administration of amiodarone in rabbits.
Lessa MA; Tibiriçá E
Fundam Clin Pharmacol; 2005 Apr; 19(2):165-72. PubMed ID: 15810896
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
[TBL] [Abstract][Full Text] [Related]
7. Amiodarone -- waxed and waned and waxed again.
Doggrell SA
Expert Opin Pharmacother; 2001 Nov; 2(11):1877-90. PubMed ID: 11825323
[TBL] [Abstract][Full Text] [Related]
8. Rate-dependent effects of lidocaine on cardiac dynamics: Development and analysis of a low-dimensional drug-channel interaction model.
Docken SS; Clancy CE; Lewis TJ
PLoS Comput Biol; 2021 Jun; 17(6):e1009145. PubMed ID: 34185778
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Podrid PJ
Chest; 1985 Oct; 88(4):618-24. PubMed ID: 3930162
[No Abstract] [Full Text] [Related]
10. [The pro-arrhythmic effects of anti-arrhythmia agents].
Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone therapy in patients implanted with cardioverter-defibrillator for life-threatening ventricular arrhythmias.
Satomi K; Kurita T; Takatsuki S; Yokoyama Y; Chinushi M; Tsuboi N; Nitta T; Shoda M; Mitamura H
Circ J; 2006 Aug; 70(8):977-84. PubMed ID: 16864928
[TBL] [Abstract][Full Text] [Related]
12. The role of amiodarone in contemporary management of complex cardiac arrhythmias.
Mujović N; Dobrev D; Marinković M; Russo V; Potpara TS
Pharmacol Res; 2020 Jan; 151():104521. PubMed ID: 31756386
[TBL] [Abstract][Full Text] [Related]
13. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
14. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Kudenchuk PJ; Brown SP; Daya M; Rea T; Nichol G; Morrison LJ; Leroux B; Vaillancourt C; Wittwer L; Callaway CW; Christenson J; Egan D; Ornato JP; Weisfeldt ML; Stiell IG; Idris AH; Aufderheide TP; Dunford JV; Colella MR; Vilke GM; Brienza AM; Desvigne-Nickens P; Gray PC; Gray R; Seals N; Straight R; Dorian P;
N Engl J Med; 2016 May; 374(18):1711-22. PubMed ID: 27043165
[TBL] [Abstract][Full Text] [Related]
15. Worsening of arrhythmias during pharmacological treatment.
Furlanello F; Gramegna L; Dal Forno P; Vergara G; Bettini R; Inama G; Disertori M
G Ital Cardiol; 1984 Oct; 14(10):798-803. PubMed ID: 6440827
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
Piccini JP; Schulte PJ; Pieper KS; Mehta RH; White HD; Van de Werf F; Ardissino D; Califf RM; Granger CB; Ohman EM; Alexander JH
Crit Care Med; 2011 Jan; 39(1):78-83. PubMed ID: 20959785
[TBL] [Abstract][Full Text] [Related]
17. Continuous intravenous antiarrhythmic agents in the intensive care unit: strategies for safe and effective use of amiodarone, lidocaine, and procainamide.
Samarin MJ; Mohrien KM; Oliphant CS
Crit Care Nurs Q; 2015; 38(4):329-44. PubMed ID: 26335213
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of lorcainide, a new anti-arrhythmic agent.
Lloyd EA; Workman LJ; Commerford PJ; Mabin TA
S Afr Med J; 1981 Dec; 60(24):929-31. PubMed ID: 7302777
[TBL] [Abstract][Full Text] [Related]
19. Amiodarone--avoid the danger of torsade de pointes.
Foley P; Kalra P; Andrews N
Resuscitation; 2008 Jan; 76(1):137-41. PubMed ID: 17716804
[TBL] [Abstract][Full Text] [Related]
20. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
